Status:
UNKNOWN
Clinical Study of Xingnaojing for the Treatment of Convulsive Diseases
Lead Sponsor:
Shenzhen Children's Hospital
Conditions:
Convulsive Diseases
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate the efficacy of Xingnaojing for the treatment of convulsive diseases; to investigate whether convulsion episodes can be induced or aggravated by Xingnaojing an...
Eligibility Criteria
Inclusion
- Febrile convulsion: positive family history of febrile convulsion; aged between 6 months and 6 years old; in accordance with the diagnosis criteria of simple type of febrile convulsion
- Frequent episodes of epilepsy: epilepsy episodes of all types; \> 3 times / week
- Refractory epilepsy: no satisfactory efficacy after treatment by 2\~3 antiepileptic drugs; ≥ 1 time / month
- Cerebral palsy: all types of cerebral palsy in children less than 3 years old. -
Exclusion
- Febrile convulsion: family history of epilepsy, complex type of febrile convulsion, epileptic episodes, febrile convulsion plus
- Frequent episodes of epilepsy: combined with advanced diseases
- Refractory epilepsy: epilepsy combined with advanced diseases
- Cerebral palsy: advanced diseases combined with backwardness or retardation of brain function development.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2010
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00796380
Start Date
December 1 2008
End Date
July 1 2010
Last Update
November 24 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.